Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
9.35
+0.26 (2.86%)
Dec 5, 2025, 4:00 PM EST - Market closed
Lexeo Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -104.97 | -98.33 | -66.39 | -59.28 | -50.62 | -5.15 |
| Depreciation & Amortization | 2.06 | 2 | 1.84 | 1.15 | 0.01 | - |
| Loss (Gain) From Sale of Investments | -3.31 | -0.02 | - | - | - | - |
| Stock-Based Compensation | 12.93 | 12.47 | 3.04 | 1.78 | 0.39 | - |
| Other Operating Activities | - | - | 0.53 | - | - | 1.87 |
| Change in Accounts Payable | -3.8 | 2.38 | -0.18 | -0.43 | 3.02 | 0.04 |
| Change in Unearned Revenue | - | - | - | -0.05 | -0.09 | 0.01 |
| Change in Income Taxes | - | - | - | -0.02 | 0.49 | 0.04 |
| Change in Other Net Operating Assets | -9.72 | 0.35 | 1.66 | 2.29 | 2.63 | 0.06 |
| Operating Cash Flow | -106.81 | -81.15 | -59.5 | -54.56 | -44.18 | -3.13 |
| Capital Expenditures | -0.4 | -0.48 | -0.12 | -0.67 | -0.19 | - |
| Sale (Purchase) of Intangibles | 0.01 | - | -0.05 | -0.23 | - | - |
| Investment in Securities | -81.76 | -93.6 | - | - | - | - |
| Investing Cash Flow | -82.15 | -94.08 | -0.17 | -0.9 | -0.19 | - |
| Short-Term Debt Issued | - | - | 4 | - | - | - |
| Long-Term Debt Issued | - | - | - | - | - | 2.6 |
| Total Debt Issued | - | - | 4 | - | - | 2.6 |
| Long-Term Debt Repaid | - | -0.41 | -0.43 | -0.16 | - | - |
| Net Debt Issued (Repaid) | -0.48 | -0.41 | 3.58 | -0.16 | - | 2.6 |
| Issuance of Common Stock | 80.33 | 95.49 | 100.3 | 0.33 | 0.17 | - |
| Repurchase of Common Stock | -0 | -0.02 | - | - | - | - |
| Other Financing Activities | -6.92 | -6.29 | -0.09 | - | -0.37 | -0.22 |
| Financing Cash Flow | 72.93 | 88.78 | 103.79 | 0.19 | 150.86 | 32.38 |
| Net Cash Flow | -116.03 | -86.45 | 44.13 | -55.27 | 106.49 | 29.25 |
| Free Cash Flow | -107.21 | -81.63 | -59.61 | -55.23 | -44.37 | -3.13 |
| Free Cash Flow Margin | - | - | - | -8445.26% | -2677.73% | -604.35% |
| Free Cash Flow Per Share | -2.51 | -2.57 | -11.13 | -33.88 | -28.58 | -2.17 |
| Cash Interest Paid | 0.13 | 0.13 | 0.18 | - | - | - |
| Cash Income Tax Paid | - | - | - | 0.08 | - | - |
| Levered Free Cash Flow | -68.58 | -48.43 | -35.22 | -33.67 | -25.48 | - |
| Unlevered Free Cash Flow | -68.52 | -48.34 | -35.1 | -33.62 | -25.48 | - |
| Change in Working Capital | -13.52 | 2.73 | 1.48 | 1.79 | 6.04 | 0.15 |
Source: S&P Capital IQ. Standard template.
Financial Sources.